Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008R. Phillip Dellinger, Jean‐Louis Vincent, Konrad Reinhart et al.|Intensive Care Medicine|2007Cited by 4.9k
Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment*Jean‐Louis Vincent, Jonathan Janes, Gordon R. Bernard et al.|Critical Care Medicine|2005Cited by 321
Recombinant Tissue Factor Pathway Inhibitor in Severe Community-acquired Pneumonia: A Randomized TrialRichard G. Wunderink, Steven M. Opal, Pierre-François Laterre et al.|American Journal of Respiratory and Critical Care Medicine|2011Cited by 128